Qiao, P., Ayat, N., Vaidya, A., Gao, S., Sun, W., Chou, S., Han, Z., Gilmore, H., Winter, J., & Lu, Z.(2020).Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts.Frontiers in Oncology,10
Vaidya, A., Wang, H., Qian, V., Gilmore, H., & Lu, Z.(2020).Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells.Cells,9(8).
Sun, D., Schur, R., Sears, A., Gao, S., Vaidya, A., Sun, W., Maeda, A., Kern, T., Palczewski, K., & Lu, Z.(2020).Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.Molecular Therapy,28(1),293-303.
Vaidya, A., Ayat, N., Buford, M., Wang, H., Shankardass, A., Zhao, Y., Gilmore, H., Wang, Z., & Lu, Z.(2020).Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.Theranostics,10(24),11127-11143.
Sun, D., Sahu, B., Gao, S., Schur, R., Vaidya, A., Maeda, A., Palczewski, K., & Lu, Z.(2017).Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis..Molecular therapy. Nucleic acids,7, 42-52.
Sun, D., Sahu, B., Gao, S., Schur, R., Vaidya, A., Akiko, M., Palczewski, K., & Lu, Z.(2017).Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-Viral Gene Therapy for Leber's Congenital Amaurosis.Molecular Therapy Nucleic Acids.
Gujrati, M., Vaidya, A., Mackey, M., Snyder, D., Malamas, A., & Lu, Z.(2016).Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy..Advanced healthcare materials,5(22),2882-2895.
Gujrati, M., Vaidya, A., & Lu, Z.(2016).Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery..Bioconjugate chemistry,27(1),19-35.
Gujrati, M., Vaidya, A., & Lu, Z.(2016).Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.Bioconjugate Chemistry [10431802],27(1),19-35.